financetom
Business
financetom
/
Business
/
UBS shares soar as profit smashes forecasts, share buyback plans affirmed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UBS shares soar as profit smashes forecasts, share buyback plans affirmed
May 7, 2024 1:47 AM

ZURICH (Reuters) - UBS on Tuesday reported first-quarter profit that trounced forecasts and said it was sticking with plans for share buybacks over three years despite Swiss government proposals that would hike its capital requirements.

Shares in Switzerland's biggest bank jumped 8% and were on track for their biggest one-day gain since March 2023, when authorities orchestrated UBS's rescue takeover of Credit Suisse.

The bank's shares have soared nearly 50% since the merger, with investors upbeat about UBS prospects given the low acquisition costs, its huge increase in assets and - so far - its relatively smooth progress in integrating its stricken rival.

The bank's first-quarter net income, which at $1.8 billion was nearly triple analyst forecasts, marked UBS' first quarterly profit since taking over Credit Suisse. It was driven by cost-cutting and a boost from 'non-core' parts of the business that UBS inherited and wants to exit.

"This is a testament to the strength of our client franchises and progress on our integration plans," UBS CEO Sergio Ermotti said of the results.

Investors have been watching closely to see what UBS executives would say about returning cash, with buybacks and dividends a main motor behind a Europe-wide rally in bank share prices the past year.

Switzerland's government recently unveiled plans to increase capital requirements for banks deemed "too big to fail", raising concerns about whether they would impact UBS's ability to reward shareholders. UBS executives have said they have major concerns about the plans.

But Ermotti said on Tuesday that the bank was sticking with buyback plans for 2024, 2025 and 2026.

This includes a plan to repurchase up to $1 billion in shares this year as well as increase last year's dividend of $0.70 per share by a mid-teen percentage in 2024.

NET NEW ASSETS

Pre-provision profits in UBS core businesses came in 10% above expectations, while revenues in asset management and investment banking fell short of forecasts, RBC analysts said.

UBS' wealth management arm also reported $27 billion in net new assets for the first quarter of the year, compared to $22 billion for the three months prior.

The bank, however, flagged that lower lending and deposit volumes as well as lower interest rates in Switzerland could impact the bank's wealth management division.

UBS said that it had achieved an additional $1 billion in gross cost savings in the first quarter, taking total savings since the merger to $5 billion. It is aiming to achieve another $1.5 billion in savings by the end of the year.

The historic deal to merge the two global systemically important banks closed last June and was followed by two quarters of losses for UBS as it absorbed Credit Suisse.

The merger of the main parent companies is expected to be legally completed on May 31, and the merger of their Swiss branches in the third quarter.

This year is expected to be a pivotal year for UBS as it tackles some of the trickier stages of integration such as combining separate IT systems and legal entities, migrating clients from Credit Suisse to UBS and cutting the banks' workforce.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PharmaCorp Rx Upsizes Bought-Deal Public Offering of Share Units to $20 Million
PharmaCorp Rx Upsizes Bought-Deal Public Offering of Share Units to $20 Million
Nov 6, 2025
12:55 PM EST, 11/06/2025 (MT Newswires) -- PharmaCorp Rx (PCRX.V) on Thursday said it is upsizing a bought-deal share offering to $20 million, up from its prior $15 million target. The company will now sell underwriters 47.7-million units priced at $0.42 apiece and made up of a share and one-half of a two-year warrant to buy a share for $0.50....
HPSG's uLeadership Acquisition Deepens Its Investment in Nurse Leadership Development
HPSG's uLeadership Acquisition Deepens Its Investment in Nurse Leadership Development
Nov 6, 2025
PENSACOLA, Fla., Nov. 6, 2025 /PRNewswire/ -- Healthcare Plus Solutions Group® (HPSG)—a leader development and coaching firm founded by healthcare veterans and visionaries Quint Studer and Dan Collard—has acquired uLeadership®, a nationally and internationally recognized professional development and research company focused on relational leadership education for nurse leaders. The founders of uLeadership—Dr. Kay Kennedy, CEO; Dr. Lucy Leclerc, chief innovation and learning officer; and...
What's Going On With Marvell Technology Stock Today?
What's Going On With Marvell Technology Stock Today?
Nov 6, 2025
Shares of Marvell Technology, Inc. ( MRVL ) are rising Thursday following a news report about a potential sale of the semiconductor company. MRVL is biding its time at current levels. Get the latest updates here. What To Know: Japanese conglomerate SoftBank considered purchasing Marvell ( MRVL ) earlier in 2025, according to a Bloomberg report. The report indicates that SoftBank...
Texas Attorney General Files Motion to Stop Kenvue From Paying November Dividends
Texas Attorney General Files Motion to Stop Kenvue From Paying November Dividends
Nov 6, 2025
12:31 PM EST, 11/06/2025 (MT Newswires) -- Attorney General Ken Paxton filed a motion in a Texas District court on Wednesday to prevent Kenvue ( KVUE ) from paying a Nov. 26 dividend and also sought an injunction to stop it from marketing Tylenol as safe for pregnant women. The motion comes days after Paxton sued the Tylenol maker and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved